Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 8, 2007

Primary Completion Date

August 10, 2007

Study Completion Date

August 10, 2007

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

14C-SB649868

SB-649868 will be provided as powder in a bottle which will be reconstituted into a solution prior to dosing via a hard gelatin capsule. Each subject will receive one unit dose of SB-649868 30 milligram reconstituted powder presented in a size 00 capsule once. The capsule will be swallowed with 160 milliliters of water.

Trial Locations (1)

EH33 2NE

GSK Investigational Site, Tranent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00520663 - Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug | Biotech Hunter | Biotech Hunter